Central and Peripheral Airway Sites of Nitric Oxide Gas Exchange in COPD

被引:22
|
作者
Gelb, Arthur F. [1 ,3 ]
Taylor, Colleen Flynn
Krishnan, Anita
Fraser, Christine
Shinar, Chris M. [4 ]
Schein, Mark J. [2 ]
Osann, Kathryn [5 ]
机构
[1] Lakewood Reg Med Ctr, Div Pulm, Dept Med, Lakewood, CA USA
[2] Lakewood Reg Med Ctr, Dept Radiol, Lakewood, CA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[4] Orange Coast Mem Med Ctr, Dept Performance Improvement & Patient Safety, Fountain Valley, CA USA
[5] Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92717 USA
关键词
OBSTRUCTIVE PULMONARY-DISEASE; EXHALED AIR; FLOW-RATE; ALVEOLAR; ASTHMA; EXACERBATIONS; INFLAMMATION; HEALTHY; SPUTUM; NO;
D O I
10.1378/chest.09-1522
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: This study investigated sites of nitric oxide (NO) gas exchange and response to inhaled corticosteroids (ICS) in patients with COPD and varying extents of emphysema. Methods: This was a prospective, randomized, single-blind, crossover study in treated, stable, ex-smoking patients with COPD who were ICS and leukotriene receptor antagonists naive. Lung function, high-resolution thin-section CT scan of the lung, and exhaled NO were measured at 50, 100, 150, and 200 mL/s. Airway NO was adjusted for NO axial backdiffusion. Results: In 39 (18 women), clinically stable ex-smokers with COPD aged 73 +/- 9 years (mean +/- SD) on salmeterol 50 mu g (S50) bid, after 180 mu g aerosolized albuterol, FEV1 (L) was 52% +/- 12% predicted and FEV1/FVC was 55% +/- 6%. Compared with 20 (12 men) age-matched controls, 39 patients with COPD had normal large airway NO flux and small airway/alveolar NO. Subsequently, 19 patients with COPD (Group A) were randomized and continued on S50, and 20 (Group B) were randomized to fluticasone propionate 250 mu g (F250)/S50 bid for 86 +/- 16 days. Group A (S50) patients were then switched to F250/S50, and 12 of 19 completed 77 +/- 15 days; there was significant (P < .001) reduction only in the exhaled fraction of NO (FENO) at 50 mL/s and large airway NO flux. In 20 patients with COPD initially randomized to F250/S50 (Group B), after 57 +/- 22 days of S50 in 16 of 20 patients there was a significant (P = .04) increase only in (FENO) at 50 mL/s and large airway NO flux, which was not reduced after 60 +/- 23 days of fluticasone propionate 100 mu g (F100)/S50(P = .07). There was no correlation between NO gas exchange and CT-scored emphysema. Conclusions: In COPD, there was; normal NO gas exchange in both large and small airways/alveoli and only large airway NO flux was suppressed with F250/S50 but not F100/S50, despite varying extents of emphysema. Peripheral NO must be corrected for axial NO backdiffusion to avoid spurious conclusions. CHEST 2010; 137(3):575-584
引用
收藏
页码:575 / 584
页数:10
相关论文
共 50 条
  • [21] Alveolar nitric oxide concentration reflects peripheral airway obstruction in stable asthma
    Fujisawa, Tomoyuki
    Yasui, Hideki
    Akamatsu, Taisuke
    Hashimoto, Dai
    Enomoto, Noriyuki
    Inui, Naoki
    Nakamura, Yutaro
    Maekawa, Masato
    Suda, Takafumi
    Chida, Kingo
    RESPIROLOGY, 2013, 18 (03) : 522 - 527
  • [22] Exhaled Nitric Oxide in COPD
    Bikov, Andras
    Meszaros, Martina
    Lazar, Zsofia
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2019, 15 (02) : 71 - 78
  • [23] Clinical Utility of Central and Peripheral Airway Nitric Oxide in Aging Patients with Stable and Acute Exacerbated Chronic Obstructive Pulmonary Disease
    Fan, Xiaodong
    Zhao, Nian
    Yu, Zhen
    Yu, Haoda
    Yin, Bo
    Zou, Lifei
    Zhao, Yinying
    Qian, Xiufen
    Sai, Xiaoyan
    Qin, Chu
    Fu, Congli
    Hu, Caixia
    Di, Tingting
    Yang, Yue
    Wu, Yan
    Bian, Tao
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 571 - 580
  • [24] Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD
    Csoma, Balazs
    Bikov, Andras
    Nagy, Lajos
    Toth, Bence
    Tabi, Tamas
    Szucs, Gergo
    Komlosi, Zsolt Istvan
    Mueller, Veronika
    Losonczy, Gyoergy
    Lazar, Zsofia
    RESPIRATORY RESEARCH, 2019, 20 (1):
  • [25] Repeatability of exhaled nitric oxide measurements in patients with COPD
    Rouhos, Annamari
    Kainu, Annette
    Piirila, Paivi
    Sarna, Seppo
    Lindqvist, Ari
    Karjalainen, Jouko
    Sovijarvi, Anssi R. A.
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2011, 31 (01) : 26 - 31
  • [26] Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with COPD
    Aydin, Murat
    Altintas, Nejat
    Mutlu, Levent
    Bilir, Bulent
    Oran, Musatfa
    Tukubas, Feti
    Topcu, Birol
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [27] Nitric oxide gas phase release in human small airway epithelial cells
    Jiang, Jingjing
    Malavia, Nikita
    Suresh, Vinod
    George, Steven C.
    RESPIRATORY RESEARCH, 2009, 10
  • [28] Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD
    Negewo, Netsanet A.
    McDonald, Vanessa M.
    Baines, Katherine J.
    Wark, Peter A. B.
    Simpson, Jodie L.
    Jones, Paul W.
    Gibson, Peter G.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 1495 - 1504
  • [29] NITRIC-OXIDE AND AIRWAY DISEASE
    BARNES, PJ
    ANNALS OF MEDICINE, 1995, 27 (03) : 389 - 393
  • [30] Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study
    Donohue, James F.
    Herje, Nancy
    Crater, Glenn
    Rickard, Kathleen
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2014, 9 : 745 - 751